The Latest Breaking News from IDXX

IDEXX Laboratories plans to report its fiscal fourth-quarter earnings next month, and analysts expect its profit to rise in the single digits.

IDEXX Laboratories has continued to underperform the S&P 500 over the past year, yet analysts remain moderately bullish on the stock’s prospects.

IDEXX Laboratories will unveil its Q2 earnings next month, and analysts anticipate a single-digit bottom-line growth.

The pet care industry’s robust expansion is driven by rising disposable income, adoption of e-commerce platforms, and rising pet ownership. Therefore, investors could consider watching fundamentally sound pet care stocks, Zoetis (ZTS), IDEXX Laboratories (IDXX), and Chewy (CHWY). Keep reading.

The healthcare industry's growth is driven by expanding healthcare needs, fast-rising demand for care services, and the increasing demand for smart medical devices. Given this backdrop, investors could consider buying fundamentally strong healthcare stocks such as IDEXX Laboratories (IDXX), Veeva Systems (VEEV), and Chemed Corporation (CHE) given their solid profitability…

IDXX Laboratories has recently underperformed the Healthcare sector, but Wall Street analysts are moderately optimistic about the stock’s prospects.

With an aging population worldwide, the rising prevalence of chronic diseases, and numerous technological advancements, the medical device sector stands primed for considerable growth and expansion. The industry tailwinds should benefit medical device stocks T2 Biosystems (TTOO) and IDEXX Laboratories (IDXX). However, which stock is poised for better gains this…

The Nasdaq is up 6.44% in 2023, its best start to a new year since 2019. These are the big Nasdaq winners, including some megacaps.

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 3.0% on an annualized basis producing an average annual return of 9.28%. Currently, IDEXX Laboratories has a market capitalization of $30.26 billion.